2019
Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder
DeVito EE, Carroll KM, Babuscio T, Nich C, Sofuoglu M. Randomized placebo-controlled trial of galantamine in individuals with cocaine use disorder. Journal Of Substance Use And Addiction Treatment 2019, 107: 29-37. PMID: 31757262, PMCID: PMC6918721, DOI: 10.1016/j.jsat.2019.08.009.Peer-Reviewed Original ResearchConceptsCocaine use disorderSignificant treatment group differencesUse disordersEfficacy of galantamineTreatment-seeking cocaine usersCurrent cocaine use disordersGroup differencesCocaine use outcomesSample of individualsTreatment group differencesComorbid opioid use disorderMethadone-maintained individualsMemory capacityAbstinent individualsCocaine useCognitive improvementCognitive outcomesCocaine use reductionCognitive functionUse outcomesCocaine usersGalantamine groupIndividualsDisordersInitial promise
2015
Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention
Rezapour T, DeVito EE, Sofuoglu M, Ekhtiari H. Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention. Progress In Brain Research 2015, 224: 345-369. PMID: 26822366, DOI: 10.1016/bs.pbr.2015.07.022.Peer-Reviewed Original ResearchConceptsNeurocognitive rehabilitationNeurocognitive deficitsCognitive neuroscienceDrug addictionAddiction treatmentLong-term abstinenceExecutive controlCognitive rehabilitationSustained attentionFlexible delivery methodsCognitive improvementAddictive behaviorsCognitive functionAddiction medicineNeurocognitive functionAddictive disordersEarly abstinencePsychosocial therapySustained abstinenceAbstinenceAddictionNeuroscienceDeficitsTreatment adherenceDrug use